定量PSMA PET/CT参数联合视觉分析提升原发性前列腺癌局部分期准确性
该单中心回顾性研究纳入223例中高危原发性前列腺癌患者,在机器人辅助根治性前列腺切除术前行PSMA PET/CT分期,评估定量参数联合视觉miT分期的价值。结果显示LCC、PSMA-vol等参数为pT3期独立预测因子,联合模型对≥pT3b期AUC达0.79,优于单纯视觉评估。
要点
- LCC是pT3a期的唯一独立预测因子
- miT分期、LCC和PSMA-vol是≥pT3b期的独立预测因子
- 联合模型对≥pT3b期AUC为0.79,优于单纯视觉评估
核心结论
- PSMA PET/CT定量参数可提高检测前列腺癌包膜外侵犯的诊断准确性,尤其对≥pT3b期病变,优于单纯视觉miT分期。
研究设计与样本
- 单中心回顾性队列研究,纳入223例中高危原发性前列腺癌患者,术前行PSMA PET/CT分期后接受机器人辅助根治性前列腺切除术,以病理分期为参考标准。
主要发现
- 单变量分析中各影像参数对pT3a的AUC为0.53–0.63,对≥pT3b为0.64–0.74,对总体≥pT3期为0.59–0.69。
- 多变量分析中LCC是pT3a期的唯一独立预测因子;miT分期、LCC和PSMA-vol是≥pT3b期的独立预测因子;LCC联合PSMA-vol是总体≥pT3期的独立预测因子。
- 联合临床风险模型对pT3a、≥pT3b和总体≥pT3期的AUC分别为0.62、0.79和0.70。
关键数值与推荐
- 定量参数包括SUVmax、SUVpeak、肿瘤体积(PSMA-vol)、总病灶PSMA表达(PSMA-TL)和肿瘤最长包膜接触(LCC)。
临床怎么用
- 在PSMA PET/CT视觉评估基础上,可结合LCC和PSMA-vol等定量参数辅助判断前列腺癌包膜外侵犯,尤其关注≥pT3b期病变。
局限性
- 单中心回顾性设计可能限制结论的普遍性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Prostate-specific membrane antigen (PSMA) PET/CT is recognized as the most accurate imaging modality for staging of patients with intermediate and high-risk prostate cancer (PCa). PSMA PET/CT has also shown potential in the local (T) staging of primary PCa. The purpose of this study was to explore the value of quantitative PSMA PET/CT parameters in addition to the standard visual assessment for local T-stage classification in a large single-center retrospective cohort. METHODS: Sequential intermediate- and high-risk primary PCa patients who underwent staging PSMA PET/CT prior to robot-assisted radical prostatectomy were included. Visual assessment of T-stage (miT-stage) was performed alongside quantitative analysis of PSMA PET/CT parameters, including SUVmax, SUVpeak, tumor volume (PSMA-vol), total lesion PSMA expression (PSMA-TL), and tumor longest capsule contact (LCC). The pathological tumor stage derived from radical prostatectomy specimens served as the reference standard. Univariable and multivariable logistic regression analyses were performed to develop clinical risk models for predicting pT3-stage disease. RESULTS: A total of 223 evaluable patients with PSMA-positive primary PCa were included. Univariable analyses of individual imaging parameters yielded AUCs of 0.53–0.63 for pT3a, 0.64–0.74 for ≥ pT3b, and 0.59–0.69 for overall ≥ pT3-stage. In multivariable analyses, LCC was the sole independent predictor for pT3a stage; miT-stage, LCC, and PSMA-vol were independent predictors for ≥ pT3b-stage; and LCC together with PSMA-vol were independent predictors for overall ≥ pT3-stage. Clinical risk models incorporating these predictors achieved AUCs of 0.62 for pT3a, 0.79 for ≥ pT3b, and 0.70 for ≥ pT3-stage. CONCLUSION: Quantitative parameters derived from PSMA PET/CT scans provide additional diagnostic accuracy for detecting extraprostatic tumor extension, particularly for ≥ pT3b-stage disease, outperforming visual assessment (miT-stage) alone.
引用
- Donswijk ML, Ettema RH, Wondergem M, et al. Addition of quantitative imaging parameters to visual analysis improves the accuracy of PSMA PET/CT for the local staging of primary prostate cancer. Eur J Nucl Med Mol Imaging. 2026. PMID: 41686217. doi:10.1007/s00259-025-07757-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。